IoT-Based Water Quality Assessment System for Industrial Waste WaterHealthcare Perspective

The environment, especially water, gets polluted due to industrialization and urbanization. Pollution due to industrialization and urbanization has harmful effects on both the environment and the lives on Earth. This polluted water can cause food poisoning, diarrhea, short-term gastrointestinal problems, respiratory diseases, skin problems, and other serious health complications. In a developing country like Bangladesh, where ready-made garments sector is one of the major sources of the total Gross Domestic Product (GDP), most of the wastes released from the garment factories are dumped into the nearest rivers or canals. Hence, the quality of the water of these bodies become very incompatible for the living beings, and so, it has become one of the major threats to the environment and human health. In addition, the amount of fish in the rivers and canals in Bangladesh is decreasing day by day as a result of water pollution. Therefore, to save fish and other water animals and the environment, we need to monitor the quality of the water and find out the reasons for the pollution. Real-time monitoring of the quality of water is vital for controlling water pollution. Most of the approaches for controlling water pollution are mainly biological and lab-based, which takes a lot of time and resources. To address this issue, we developed an Internet of Things (IoT)-based real-time water quality monitoring system, integrated with a mobile application. The proposed system in this research measures some of the most important indexes of water, including the potential of hydrogen (pH), total dissolved solids (TDS), and turbidity, and temperature of water. The proposed system results will be very helpful in saving the environment, and thus, improving the health of living creatures on Earth

Analysis of C-reactive protein level in SARS-CoV-2 patients and its role in predicting the severity of SARS-CoV-2 infection

Introduction: Corona Virus Disease-19 (COVID-19) pandemic is a public health emergency due to the spread of 2019 novel Corona Virus (2019-nCoV), also called as Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). Analysis of CRP along with various other haematological parameters serves as a predictor of infection and inflammation. Aims and objectives: The aim of the study was to study the CRP level in SARS-CoV-2 patients and its role in predicting the severity of infection. Materials and Methods: As many as 768 patients were included in this study. Serum samples were analysed for CRP levels by Quantitative CRP test, based on the principle of Latex turbidimetry. CRP values equal to or greater than 6mg/L were considered as abnormal. Results: Out of 768 serum samples tested, 337 (43.8%) samples showed abnormal values. Out of which 255 (75.7%) were male patients and 82(24.3%) were female patients. A total of 42.4% patients had increased CRP values that belonged to the age group 41-60 years followed by 29% patients that belonged to the age group of 61-80 years. In the age group of 61-80 years 67/98 (68%) patients deteriorated during hospitalization and required mechanical ventilation and the mortality rate was 88% among patients on mechanical ventilation. Conclusion: Our study suggested that CRP testing may be useful as an earlier indicator for severe illness and those presenting with marked increase of > 45.6 mg/L should be paid more attention. Male preponderance was detected and elderly patients revealed abnormal values of CRP as compared to young and middle-aged patients

Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003

To prevent future epidemics, enhanced quality assurance is essential

Harnessing genomics to improve health in the Eastern Mediterranean Region – an executive course in genomics policy

BACKGROUND: While innovations in medicine, science and technology have resulted in improved health and quality of life for many people, the benefits of modern medicine continue to elude millions of people in many parts of the world. To assess the potential of genomics to address health needs in EMR, the World Health Organization's Eastern Mediterranean Regional Office and the University of Toronto Joint Centre for Bioethics jointly organized a Genomics and Public Health Policy Executive Course, held September 20(th)–23(rd), 2003, in Muscat, Oman. The 4-day course was sponsored by WHO-EMRO with additional support from the Canadian Program in Genomics and Global Health. The overall objective of the course was to collectively explore how to best harness genomics to improve health in the region. This article presents the course findings and recommendations for genomics policy in EMR. METHODS: The course brought together senior representatives from academia, biotechnology companies, regulatory bodies, media, voluntary, and legal organizations to engage in discussion. Topics covered included scientific advances in genomics, followed by innovations in business models, public sector perspectives, ethics, legal issues and national innovation systems. RESULTS: A set of recommendations, summarized below, was formulated for the Regional Office, the Member States and for individuals. • Advocacy for genomics and biotechnology for political leadership; • Networking between member states to share information, expertise, training, and regional cooperation in biotechnology; coordination of national surveys for assessment of health biotechnology innovation systems, science capacity, government policies, legislation and regulations, intellectual property policies, private sector activity; • Creation in each member country of an effective National Body on genomics, biotechnology and health to: - formulate national biotechnology strategies - raise biotechnology awareness - encourage teaching and training of biotechnology - devise integration of biotechnology within national health systems. CONCLUSION: The recommendations provide the basis for a road map for EMR to take steps to harness biotechnology for better and more equitable health. As a result of these recommendations, health ministers from the region, at the 50th Regional Committee Meeting held in October 2003, have urged Member States to establish national bodies of biotechnology to formulate a strategic vision for developing biotechnology in the service of the region's health. These efforts promise to raise the profile of genomics in EMR and increase regional cooperation in this exciting new field

Prevention of malaria in Afghanistan through social marketing of insecticide-treated nets: evaluation of coverage and effectiveness by cross-sectional surveys and passive surveillance.

Malaria is often a major health problem in countries undergoing war or conflict owing to breakdown of health systems, displacement of vulnerable populations, and the increased risk of epidemics. After 23 years of conflict, malaria has become prevalent in many rural areas of Afghanistan. From 1993 to the present, a network of non-governmental organizations, co-ordinated by HealthNet International, has operated a programme of bednet sales and re-treatment in lowland areas. To examine whether a strategy based on insecticide-treated nets (ITN) is a viable public health solution to malaria, communities were given the opportunity to buy nets and then monitored to determine population coverage and disease control impact. This was carried out using two contrasting methods: cross-sectional surveys and passive surveillance from clinics using a case-control design. Nets were purchased by 59% of families. Cross-sectional surveys demonstrated a 59% reduction in the risk of Plasmodium falciparum infection among ITN users compared with non-users (OR 0.41; 95% CI 0.25-0.66). The passive surveillance method showed a comparable reduction in the risk of symptomatic P. falciparum malaria among ITN users (OR 0.31; 95% CI 0.21-0.47). The cross-sectional method showed a 50% reduction in risk of P. vivax infection in ITN users compared with non-users (OR 0.50; 95% CI 0.17-1.49) but this effect was not statistically significant. The passive surveillance method showed a 25% reduction in the risk of symptomatic P. vivax malaria (OR 0.75; 95% CI 0.66-0.85). ITN appeared to be less effective against P. vivax because of relapsing infections; hence an effect took more than one season to become apparent. Passive surveillance was cheaper to perform and gave results consistent with cross-sectional surveys. Untreated nets provided some protection. Data on socioeconomic status, a potential confounding factor, was not collected. However, at the time of net sales, there was no difference in malaria prevalence between buyers and non-buyers. The abundance of Anopheles stephensi, the main vector, did not appear to be affected by ITN. ITN constitute one of the few feasible options for protection against malaria in chronic emergencies